Keywords: sanofi, lilly, develop, oxaliplatin, usa, forged, joint-venture

Sanofi, Lilly to develop oxaliplatin in USA

Article | 20 April 1999

Print This

Sanofi has forged a joint-venture agreement with Eli Lilly for thedevelopment and marketing of Eloxatin (oxaliplatin), a drug for metastatic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in